Update on current diagnosis and management of anaplastic thyroid carcinoma

doi:10.5306/wjco.v14.i12.570

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4147)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

WORD

HTML

2979

Figures (1-3)

181

Tables (1-4)

168

Sum=3400

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

106

Download

239

Sum=345

Publishing Process of This Article

Item

Count

Browse

Download

167

Sum=237

Dec 24, 2023 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Dec 24, 2023; 14(12): 570-583
Published online Dec 24, 2023. doi: 10.5306/wjco.v14.i12.570

Table 1 Used diagnostic tools for anaplastic thyroid carcinoma

n	Modality
1	Plain ultrasound or preferably high resolution ultrasound
2	Core needle biopsy under ultrasound guidance preferably
3	FNA cytology under ultrasound guidance
4	Staging imaging (CT, MRI-MRA, ¹⁸F-FDG PET-CT)
5	Bronchoscopy
6	Esophagoscopy
8	Fiberoptic laryngoscopy
9	Molecular testing (BRAF, MEK, NTRK, RET, RAS, p53 genes)
10	MicroRNAs
11	PD-L1 expression
12	Liquid biopsy
13	Histopathology
14	Pathological TNM staging

FNA: Fine-needle aspiration; CT: Computed tomography; MRI-MRA: Magnetic resonance imaging/magnetic resonance angiography; ¹⁸F-FDG PET-CT: [(18)F]fluoro-D-glucose positron emission tomography/computed tomography; PD-L1: Programmed death-ligand 1; TNM: Tumor-node-metastasis.

Citation: Pavlidis ET, Galanis IN, Pavlidis TE. Update on current diagnosis and management of anaplastic thyroid carcinoma. World J Clin Oncol 2023; 14(12): 570-583
URL: https://www.wjgnet.com/2218-4333/full/v14/i12/570.htm
DOI: https://dx.doi.org/10.5306/wjco.v14.i12.570